Sign In

Nathan Sigworth

Increasing access to innovative therapies

Nathan Sigworth is an entrepreneur and innovator in the healthcare technology sector, currently serving as the Co-Founder and CEO of PharmaCCX, which has been rebranded as CCX.2 He is a graduate of Dartmouth College and has been recognized as an Echoing Green Fellow and a PopTech Fellow.1

Sigworth's career has been focused on improving healthcare access and combating counterfeit drugs. He began his entrepreneurial journey by founding PharmaSecure in India, where he developed technology to protect pharmaceutical supply chains from counterfeiting.13 Under his leadership, PharmaSecure grew to protect the distribution of 1.2 billion medicine packages across more than 30 countries.3

After his success with PharmaSecure, Sigworth co-founded CCX (formerly PharmaCCX) in November 2017.4 CCX applies technology to support market access for both payers and pharmaceutical companies, aiming to increase access to innovative therapies.12

Throughout his career, Sigworth has received several accolades:

  • Recognized by Inc Magazine as one of the 30 Entrepreneurs under the age of 303
  • Awarded 1st Place in the Dartmouth Business Plan Competition in 20064
  • Received the 2006 Next Generation Breakthrough Award from Popular Mechanics4
  • Granted the Grand Challenges in TB Control Grant by USAID, IKP, and Gates Foundation in 20144

Sigworth's entrepreneurial spirit was evident even during his college years when he invented the Gyrobike, a gyroscopic replacement for training wheels, which he later licensed and sold.5

His LinkedIn profile username is nathan-sigworth-8b3b939, as mentioned in the query.

Highlights

May 30 · linkedin

“As companies and regulators, we prioritize certain endpoints. Patients sometimes prioritize different ones.”

At The Galien Foundation’s #PrixGalien forum today, Mel Walker facilitated an excellent panel with Robyn Bent, Sarah Gheuens, Maria Mavris, and Elizabeth Vroom on the importance of including patients in pharma and regulatory process and decisions.

May 14 · linkedin

On May 1st, Professor Christopher McCabe and Dr Felicity Lamrock of Queen's University Belfast organized an excellent event bringing together leaders from academia and market access to share our learnings and compare notes. Dr. James Francis O'Mahony from University College Dublin spoke about opportunity cost and evidence-based thresholds. Building on this, Dr. Mike Paulden from University of Alberta shared a framework for fair pricing involving implications for population health and opportunity cost. Dr. Jeff Round from IHE and University of Alberta shared about risk – Recognizing that there’s diversity in payers wanting to internalize risk or wanting to eliminate risk with implications for access solutions. Dr. Roisin Adams from the National Centre Pharmacoeconomics in Dublin- spoke about the practicalities of bringing theory to life – especially the transformational work of multi-regional HTA. I shared some of my team’s learnings in streamlining negotiations and the administration of access agreements. And Chris did a great job of weaving all this together and sparking lively discussion. It was great to have academics, payers, regulators, industry leaders together in one place. Reconnecting with old friends and and getting to know some new ones. Really nicely done Chris, Felicity, and all the others involved in this event!

Related Questions

What inspired Nathan Sigworth to transition from PharmaSecure to PharmaCCX?
How does PharmaCCX's technology differ from that of PharmaSecure?
What are some of the key challenges Nathan Sigworth has faced in his career?
How has Nathan Sigworth's work impacted the global pharmaceutical industry?
What are Nathan Sigworth's future plans for PharmaCCX?
Nathan Sigworth
Nathan Sigworth, photo 1
Nathan Sigworth, photo 2
Add to my network

Location

Zug, Zug, Switzerland